United Therapeutics Corp (NASDAQ:UTHR)

122.17
Delayed Data
As of 4:00pm ET
 -12.79 / -9.48%
Today’s Change
112.01
Today|||52-Week Range
169.89
-17.42%
Year-to-Date
No recent news for United Therapeutics Corp.

Today’s Trading

Previous close134.96
Today’s open134.30
Day’s range120.68 - 134.30
Volume1,675,068
Average volume (3 months)417,435
Market cap$5.8B
Data as of 4:00pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)+19.89%
Earnings growth (this year)-16.45%
Earnings growth (next 5 years)-8.45%
Revenue growth (last year)+9.08%
P/E ratio10.8
Price/Sales4.20
Price/Book3.13

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...-0.49-1.44%
GRFSGrifols SA-0.14-0.61%
IONSIonis Pharmaceutical...-0.13-0.26%
----
Data as of 4:02pm ET, 02/21/2018

Financials

Next reporting dateFebruary 27, 2018
EPS forecast (this quarter)$4.00
Annual revenue (last year)$1.6B
Annual profit (last year)$713.7M
Net profit margin44.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts